Predictive oncology stock.
What this means: Predictive Oncology Inc (POAI) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives POAI a rank of 10. Our methodology considers analysis of the company's financial situation and how it has traded recently. POAI rank of 10 means that it ranks below 90% of stocks.
In today’s data-driven world, businesses are constantly seeking ways to gain a competitive edge. One powerful tool that has emerged in recent years is predictive analytics programs.Quotes Summary Real-Time After-Hours Pre-Market Key Data Bid Price and Ask Price The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is …4 analysts have issued 12 month price targets for Ikena Oncology's stock. Their IKNA share price targets range from $11.00 to $13.00. On average, they expect the company's share price to reach $11.67 in the next twelve months. This suggests a possible upside of 677.8% from the stock's current price.Predictive Oncology Inc. (POAI) is a science-driven company that leverages its AI and machine learning capabilities to accelerate oncologic drug discovery and enable drug development. The stock price, news, quote and history of POAI are shown on Yahoo …
FOSTER CITY, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Notable Labs, Ltd. (“Notable”) (Nasdaq: NTBL), a clinical stage therapeutic platform company …Aug 10, 2023 · Predictive Oncology Inc. 2.9722. +0.0322. +1.10%. Company to host investor call and webcast today, August 10th, at 5:30pm EDTPITTSBURGH, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology ...
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Helomics, zPREDICTA, Soluble and Skyline. It derives prime revenue from the Skyline segment which consists of the STREAMWAY System product sales, and TumorGenesis subsidiary (Research and Development) is included within corporate. The STREAMWAY System ...
About the Oncology Pharma, Inc. stock forecast. As of 2023 December 03, Sunday current price of ONPH stock is 0.001$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Oncology Pharma stock price has been showing a declining tendency so we believe that similar market segments were not …1 equities research analysts have issued 1-year target prices for Cardiff Oncology's stock. Their CRDF share price targets range from $13.00 to $13.00. On average, they expect the company's share price to reach $13.00 in the next twelve months. This suggests a possible upside of 956.9% from the stock's current price.According to the issued ratings of 5 analysts in the last year, the consensus rating for Pyxis Oncology stock is Buy based on the current 5 buy ratings for PYXS. The average twelve-month price prediction for Pyxis Oncology is $8.33 with a high price target of $14.00 and a low price target of $4.00. Learn more on PYXS's analyst rating history.PREDICTIVE ONCOLOGY INC. 2915 Commers Drive, Suite 900. Eagan, Minnesota 55121. Telephone: (651) 389-4800 . NOTICE OF SPECIAL MEETING OF STOCKHOLDERSCharles Nuzum POAI stock SEC Form 4 insiders trading. Charles has made over 1 trades of the Predictive Oncology stock since 2022, according to the Form 4 filled with the SEC. Most recently Charles bought 200,000 units of POAI stock worth $62,000 on 20 May 2022.200,000 units of POAI stock worth $62,000 on 20 May 2022.
The first split for POAI took place on October 29, 2019. This was a 1 for 10 reverse split, meaning for each 10 shares of POAI owned pre-split, the shareholder ...
Track Predictive Oncology Inc (POAI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors
Nov 17, 2023 · As of November 16, 2023, Predictive Oncology Inc had a $12.8 million market capitalization, putting it in the 16th percentile of companies in the Medical Equipment, Supplies & Distribution industry. Predictive Oncology Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. predictive oncology inc. certificate of designation of preferences, rights and limitations of. series e convertible preferred stock pursuant to section 151 of the. delaware general corporation law . effective june 13, 2019 .0.73%. $39.94B. Astellas Pharma Inc. -4.37%. ¥3.42T. PYXS | Complete Pyxis Oncology Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.The latest price target for Predictive Oncology ( NASDAQ: POAI) was reported by HC Wainwright & Co. on Wednesday, June 30, 2021. The analyst firm set a price target for 5.00 expecting POAI to rise ...Predictive Oncology (NASDAQ: POAI) is utilizing its vast repository of over 150,000 tumors by cancer type and the emerging AI technology to develop therapeutics with greater precision and ...Predictive Oncolog y : Offers a compelling use case for AI in the area of cancer research. Remark ( MARK ): One of the smallest of small-cap stocks may have one of the biggest upsides of any AI stock.
Predictive Oncology, Pittsburgh, Pennsylvania. 294 likes. Predictive Oncology (NASDAQ:POAI) Changing the landscape of oncology drug discovery & enabling the deMachine learning algorithms are at the heart of predictive analytics. These algorithms enable computers to learn from data and make accurate predictions or decisions without being explicitly programmed.Nov 17, 2023 · finance.yahoo.com - March 21 at 3:52 PM. Predictive Oncology Inc.: Predictive Oncology Announces Distribution of Series F Preferred Stock to Holders of its Common Stock. finanznachrichten.de - March 17 at 10:22 AM. Predictive Oncology and Cancer Research Horizons partner up to pursue development of cancer drugs. Predictive Oncology. Price today: US$0.4308. Market cap: US$33.671 million. Predictive Oncology is a company that is focused on the use of data and artificial intelligence to develop personalized cancer therapies, which can lead to more effective treatments and improved patient outcomes.The Price to Sales ratio or P/S is calculated as price divided by sales. After the P/E ratio, it's one of the most common valuation metrics. If the P/S ratio is 1, that means you're paying $1 for ...The estimated Net Worth of Robert L Myers is at least $351 ezer dollars as of 2 December 2022. Mr Myers owns over 8,795 units of Predictive Oncology stock worth over $23,211 and over the last 6 years he sold POAI stock worth over $0. In addition, he makes $327,838 as CFO & Sec. at Predictive Oncology.We changed our name from Skyline Medical, Inc. to Precision Therapeutics, Inc. on February 1, 2018 and to Predictive Oncology Inc. on June 13, 2019. Our address is 2915 Commers Drive, Suite 900, Eagan, Minnesota 55121. Our telephone number is (651) 389-4800, and our website address is www.predictive-oncology.com.
About the Oncology Pharma, Inc. stock forecast. As of 2023 December 03, Sunday current price of ONPH stock is 0.001$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Oncology Pharma stock price has been showing a declining tendency so we believe that similar market segments were not …POAI U.S.: Nasdaq Predictive Oncology Inc. Watch list NEW Set a price target alert Premarket Last Updated: Oct 27, 2023 7:12 a.m. EDT Delayed quote $ 2.8800 0.02 0.70% Before Hours Volume: 35...
२०२३ नोभेम्बर १४ ... ... Stock, $.01 par value, 2,300,000 shares authorized, 79,246 shares outstanding as of September 30, 2023 and December 31, 2022, 792, 792. Common ...Nov 8, 2023 · PITTSBURGH, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, announced today that it has completed a multi-year study ... Predictive Oncology appoints Bernard A. Harris, Jr., MD, MBA, venture capitalist and former NASA astronaut to serve on the company’s Business… Liked by Bob Myers Some of you know it as ...Welcome to Predictive Oncology The leading edge of a new frontier in drug discovery Integrating scientific rigor with machine learning • Overcoming challenges of clinical trials • Improving the probability of success • Collaborating with partners in biopharma • Advancing molecules to medicine with confidence and accuracy Connect with us Changing the game in drug … Home Read More »May 16, 2022 · Predictive Oncology Inc. EAGAN, Minn., May 16, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused ... Predictive Oncology Inc. (NASDAQ:POAI – Get Free Report)’s stock price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $3.98 and traded as low as $3.11. Predictive Oncology shares last traded at $3.11, with a volume of 20,587 shares. Predictive Oncology Price Performance The stock […]Dec 1, 2023 · Predictive Oncology Inc. (NASDAQ:POAI) issued its quarterly earnings results on Wednesday, August, 11th. The medical instruments supplier reported ($1.00) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.60) by $0.60. The medical instruments supplier had revenue of $0.35 million for the quarter, compared to the ... The Predictive Oncology stock forecast for tomorrow is $ 2.88, which would represent a -0.32% loss compared to the current price. In the next week, the price of POAI is expected to increase by 14.32% and hit $ 3.30. As far as the long-term Predictive Oncology stock forecast is concerned, here ... He oversees Predictive Oncology’s solubility and stability contracts for numerous pharmaceutical/biotech companies. From 1981 to 2016, Dr. DeLucas was a faculty member at the University of Alabama at Birmingham (UAB) where he served as a Professor in the School of Optometry, Senior Scientist and Director of the Comprehensive Cancer Center X ...
Nov 27, 2023 · A high-level overview of Predictive Oncology Inc. (POAI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Predictive Oncology includes various subsidiaries in the drug development and formulation space, as well as a legacy medical device business generating revenues, but this article focuses on their ...
Oncology Pharma's stock was trading at $0.3386 at the beginning of the year. Since then, ONPH shares have decreased by 99.9% and is now trading at $0.0002. View the best growth stocks for 2023 here.Common Stock Will Begin Trading on Split-Adjusted Basis on April 24, 2023. EAGAN, Minn., April 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that it is effecting a reverse stock split of its common stock at a ratio of 1 post-split share for every 20 pre ...Predictive Oncology appoints Bernard A. Harris, Jr., MD, MBA, venture capitalist and former NASA astronaut to serve on the company’s Business… Liked by Bob Myers Some of you know it as ...The current Predictive Oncology [ POAI] share price is $3.50. The Score for POAI is 29, which is 42% below its historic median score of 50, and infers higher risk than normal. POAI is currently trading in the 20-30% percentile range relative to …POAI U.S.: Nasdaq Predictive Oncology Inc. Watch list NEW Set a price target alert Premarket Last Updated: Oct 27, 2023 7:12 a.m. EDT Delayed quote $ 2.8800 0.02 0.70% Before Hours Volume: 35...POAI 2HR test Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal and associated products. It operates through the following segments: Helomics, Skyline, Soluble, and test Predictive Oncology, Inc. engages in …Track Predictive Oncology Inc (POAI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsThe shares of Series F Preferred Stock will be distributed to such recipients a. EAGAN, Minn., March 16, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: ...Oncology Pharma's stock was trading at $0.3386 at the beginning of the year. Since then, ONPH shares have decreased by 99.9% and is now trading at $0.0002. View the best growth stocks for 2023 here.What's Happening with POAI Stock Today. Predictive Oncology Inc (POAI) stock has risen 1.56% while the S&P 500 has fallen -0.05% as of 10:07 AM on Thursday, Jun 22. POAI has risen $0.06 from the previous closing price of $3.83 on volume of 25,176 shares. Over the past year the S&P 500 is higher by 16.05% while POAI has fallen -50.82%.
Predictive Oncology Inc. Company to host investor call and webcast today, May 15th, at 5:30pm EDT. EAGAN, Minn., May 15, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI) , a science ...Predictive Oncology Inc Stock (POAI) is expected to reach an average price of $47.48 in 2030, with a high forecast of $84.27 and a low forecast of $10.69. This ...Predictive Oncology Inc. (POAI) is a science-driven company that leverages its AI and machine learning capabilities to accelerate oncologic drug discovery and enable drug development. The stock price, news, quote and history of POAI are shown on Yahoo Finance, as well as related research and analysis. finance.yahoo.com - March 21 at 3:52 PM. Predictive Oncology Inc.: Predictive Oncology Announces Distribution of Series F Preferred Stock to Holders of its Common Stock. finanznachrichten.de - March 17 at 10:22 AM. Predictive Oncology and Cancer Research Horizons partner up to pursue development of cancer drugs.Instagram:https://instagram. nysearca arkfwho makes hokafthiquarters value The estimated Net Worth of J Melville Engle is at least $117 millier dollars as of 24 May 2022. Mr Engle owns over 159,500 units of Predictive Oncology stock worth over $113,900 and over the last 14 years he sold POAI stock worth over $0. In addition, he makes $3,000 as Chairman & CEO at Predictive Oncology.Dec 22, 2021 · The upgrade of Predictive Oncology Inc. to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the ... nasdaq inpxbud light beer stock Predictive Oncology (POAI) Quote Overview ... It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.View the latest Oncology Pharma Inc. (ONPH) stock price, news, historical charts, analyst ratings and financial information from WSJ. cost of pagani Their ZOM share price targets range from $6.00 to $6.00. On average, they expect the company's stock price to reach $6.00 in the next twelve months. This suggests a possible upside of 3,421.1% from the stock's current price. View analysts price targets for ZOM or view top-rated stocks among Wall Street analysts.Predictive Oncology Inc (POAI) Message Board - Company Name: Predictive Oncology Inc, Stock Symbol: POAI, Industry: Medical - Healthcare - Total Posts: 4357 - Last Post: 07/15/2023 01:24:11 PM - company/specific stock boardThe Price to Sales ratio or P/S is calculated as price divided by sales. After the P/E ratio, it's one of the most common valuation metrics. If the P/S ratio is 1, that means you're paying $1 for ...